Rome IV Criteria for IBS Diagnosis and Management
Rome IV Diagnostic Criteria
The Rome IV criteria require recurrent abdominal pain at least 1 day per week in the last 3 months (with symptom onset at least 6 months before diagnosis), associated with two or more of the following: pain related to defecation, change in stool frequency, or change in stool form/appearance. 1
Key Differences from Prior Criteria
- Rome IV is substantially more restrictive than Rome III, reducing global IBS prevalence from 10.1% to 4.1%, and identifies patients with more severe symptoms and higher psychological comorbidity 1
- Rome IV removed the term "discomfort" and requires pain specifically, unlike Rome III which accepted either pain or discomfort 2, 3
- The frequency requirement increased from "at least 3 days per month" (Rome III) to "at least 1 day per week" (Rome IV) 3
- Rome II criteria (older) required 12 weeks or more in the last 12 months of abdominal discomfort/pain with two of three features: relieved by defecation, associated with change in frequency of stool, or associated with change in consistency of stool 4
Clinical Performance
- Recent validation shows Rome IV criteria have 82.1% sensitivity and 85.1% specificity 5
- Relaxing the frequency requirement back to 3 days per month improves diagnostic performance (sensitivity 90.2%, specificity 85.1%) without sacrificing accuracy 5
- Approximately 85% of Rome III IBS patients fulfill Rome IV criteria, but 15% lose their diagnosis despite having clinically significant symptoms 3
Application to Your Patient with Constipation, Watery Stools, and RLQ Pain
Immediate Red Flag Assessment
This patient requires urgent evaluation before applying Rome IV criteria due to right lower quadrant pain, which is atypical for IBS. 4
- Right lower quadrant pain specifically raises concern for appendicitis, inflammatory bowel disease (especially Crohn's disease), or cecal pathology and should not be dismissed as IBS without investigation
- The combination of both constipation AND watery stools (alternating pattern) could represent IBS-mixed subtype, but alarm features must be excluded first 4, 6
Mandatory Exclusion Criteria
Before diagnosing IBS, you must exclude:
- Weight loss, rectal bleeding, nocturnal symptoms, or anemia - any of these mandate colonoscopy regardless of age 4, 1, 6
- Age >45 years - requires colonoscopy to exclude colorectal malignancy 7
- Fever - suggests inflammatory or infectious process 6
Diagnostic Workup Algorithm
For patients <45 years without alarm features:
- Perform complete blood count to exclude anemia 7
- Check thyroid function tests (hypothyroidism causes constipation) 4
- Consider antiendomysial antibodies for celiac disease 4
- Stool microscopy if diarrhea predominates 4
- Sigmoidoscopy with biopsies is recommended for all patients with diarrhea to detect microscopic colitis 4
For patients ≥45 years OR with alarm features:
- Complete colonoscopy to cecum is mandatory 7
- All abnormalities must be biopsied 4
- Complete the above laboratory workup as well 6
Applying Rome IV Criteria
Only after excluding organic disease, assess if the patient meets Rome IV:
- Abdominal pain at least 1 day per week for the last 3 months (with onset ≥6 months ago) 1
- Plus two or more of:
Important caveat: The Rome IV criteria were designed for research consistency and should not become a "straitjacket" - many patients with abdominal pain and disturbed bowel habit who don't exactly fit these criteria have a similar clinical course 4
Supportive Features for IBS Diagnosis
- Female sex, age <45 years, symptom duration >2 years 4, 1, 6
- Frequent prior visits for non-gastrointestinal symptoms 4, 1
- Pain relieved by defecation 4
- Looser or more frequent stools with pain onset 4
- Passage of mucus, sensation of incomplete evacuation, abdominal distension 4
Treatment Options for Confirmed IBS
First-Line Management
Positive diagnosis with explanation and reassurance is the cornerstone of management - most patients can be managed in primary care with a clear explanation of symptoms and their benign prognosis 4
- Listen to the patient's specific fears and beliefs about their symptoms 4
- Dietary fiber 25 g/day is recommended as first-line therapy for constipation-predominant symptoms 7
- Identify food intolerances (wheat and dairy products are most common in UK populations, though true food allergy is rare) 4
- Address lifestyle factors: adequate time for regular defecation, appropriate exercise 4
Pharmacological Options
Hyoscyamine sulfate is FDA-approved as adjunctive therapy for IBS (irritable colon, spastic colon, mucous colitis) to reduce symptoms including visceral spasm and hypermotility 8
- Also effective for controlling gastric secretion and associated abdominal cramps 8
- Can be used in functional intestinal disorders and spastic colitis 8
Subtype-Specific Therapy
After initial management, tailor therapy according to predominant bowel pattern:
- IBS with constipation (IBS-C): Requires hard/lumpy stools and fewer than 3 bowel movements per week in addition to Rome criteria 6
- IBS with diarrhea (IBS-D): Consider sigmoidoscopy with biopsies to exclude microscopic colitis 4
- IBS-mixed: Alternating constipation and diarrhea (as in your patient) 9
Prognosis
Once a functional diagnosis is established, the incidence of new non-functional diagnoses is extremely low - this should provide reassurance to both clinician and patient 4, 6
Critical Clinical Pitfall
Do not diagnose IBS in a patient with right lower quadrant pain without first excluding organic pathology. The Rome criteria assume typical diffuse or lower abdominal pain, not localized RLQ pain. This patient needs imaging (CT abdomen/pelvis) or colonoscopy before accepting a functional diagnosis, regardless of whether they technically meet Rome IV symptom criteria.